Evotec Says Sandoz Deal Is ‘Validation’ Of Biologics Ambitions

Chief Business Officer Matthias Evers Talks Biologics Technology Platform And Access

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.